title: Evaluating the quality of information about alternatives to research participation in oncology consent forms.
abstract: A careful consideration of the alternatives to research participation is an essential element of making an informed choice to enroll in a biomedical research study. While there is general agreement on the importance of informing prospective subjects about alternatives to research participation, little is known about how investigators communicate this information. The purpose of this study was to attempt to assess the quality of information about alternatives contained in informed consent documents in oncology randomized controlled trials. Our study indicates that there is room for improvement concerning the discussion of alternatives to research participation in informed consent documents in oncology randomized controlled trials. Though most of the documents in our study met the minimal disclosure standard found in the U.S. federal regulations, less than a third met the reasonable person standard, a widely accepted principle endorsed by the common law and various ethics guidelines and documents. There was a statistically significant difference between the alternative discussions in local and model forms (P<0.0014). The alternatives discussions in local informed consent documents were more likely to receive higher scores than those in model consent documents, with an odds-ratio of 3.5 to 1.
authors.affiliation: National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, United States. resnikd@niehs.nih.gov
authors.forename: David B
authors.initials: DB
authors.lastname: Resnik
authors.forename: Daniel
authors.initials: D
authors.lastname: Patrone
authors.forename: Shyamal
authors.initials: S
authors.lastname: Peddada
mesh_terms: D032962:Consent Forms / Q000941:ethics / Q000331:legislation & jurisprudence; D003657:Decision Making / Q000941:ethics*; D032984:Ethics, Research; D006801:Humans; D007258:Informed Consent / Q000941:ethics* / Q000331:legislation & jurisprudence*; D009369:Neoplasms / Q000628:therapy*; D010353:Patient Education as Topic / Q000941:ethics* / Q000592:standards*; D018579:Patient Selection / Q000941:ethics*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics* / Q000592:standards*